SCHEMBL25856341

SCHEMBL25856341

C#Cc1ccc(-c2nnc(N)c3ncccc23)c(O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 7/20 0.38
HSP90AB1 P08238 2/20 0.38
IDO1 P14902 1/20 0.38
PSMB5 P28074 1/20 0.38
KDM4E B2RXH2 10/20 0.37
MMP14 P50281 3/20 0.35
HTT P42858 6/20 0.35
LMNA P02545 5/20 0.35
SMN1; SMN2 Q16637 5/20 0.35
SLC6A2 P23975 4/20 0.35
MEN1 O00255 4/20 0.35
TP53 P04637 4/20 0.35
KMT2A Q03164 4/20 0.35
TDP1 Q9NUW8 4/20 0.35
USP2 O75604 3/20 0.35
ALDH1A1 P00352 3/20 0.35
ALOX15 P16050 3/20 0.35
HPGD P15428 2/20 0.35
MAPK1 P28482 2/20 0.35
HIF1A Q16665 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25858194 0.85 HSP90AA1 (0.37) HSP90AA1HSP90AB1IDO1PSMB5KDM4E
SCHEMBL30488502 0.85 KDM4E (0.38) HSP90AA1HSP90AB1IDO1PSMB5KDM4E
SCHEMBL25299180 0.85 KDM4E (0.38) HSP90AA1HSP90AB1IDO1PSMB5KDM4E
SCHEMBL25854476 0.83 KDM4E (0.43) IDO1KDM4EKMT2ABRD4NR1I2
SCHEMBL25858077 0.82 KDM4E (0.35) IDO1KDM4EHTTLMNASLC6A2
SCHEMBL27355944 0.78 HSP90AA1 (0.38) HSP90AA1HSP90AB1IDO1PSMB5KDM4E
SCHEMBL24855472 0.78 KDM4E (0.42) HSP90AA1HSP90AB1IDO1PSMB5KDM4E
SCHEMBL25854611 0.76 EP300 (0.37) IDO1
SCHEMBL25858132 0.74 ATM (0.37) HSP90AA1KDM4EMMP14HTTSMN1; SMN2
SCHEMBL25854612 0.73 NLRP3 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131277-A1 NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF 药捷安康(南京)科技股份有限公司 2023-07-13 WO disclosed